GALT Units

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch GALT Units and buy or sell other stocks, ETFs, and their options commission-free!

About GALT+

Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs target the development of carbohydrate molecules which offers alternative options to larger market segments. 

CEO
Joel Lewis
CEOJoel Lewis
Employees
9
Employees9
Headquarters
Norcross, Georgia
HeadquartersNorcross, Georgia
Founded
2000
Founded2000
Employees
9
Employees9

GALT+ Key Statistics

Market cap
260.79M
Market cap260.79M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
678.91K
Average volume678.91K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
52 Week high
52 Week low
52 Week low

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.